심장 보철 기기 시장 : 제품별, 최종 사용자별 - 세계 예측(2025-2030년)

The Cardiac Prosthetic Devices Market was valued at USD 8.63 billion in 2023, expected to reach USD 9.98 billion in 2024, and is projected to grow at a CAGR of 15.77%, to USD 24.06 billion by 2030.

Cardiac prosthetic devices encompass a range of medical devices designed to replace or support the function of a failing or surgically removed heart valve, as well as other parts of the cardiac system. These devices include artificial heart valves, pacemakers, and ventricular assist devices, addressing critical needs for patients with severe cardiovascular diseases. The necessity for such devices arises from the increasing incidence of heart diseases globally, driven by aging populations and lifestyle factors. These devices are applied in surgical procedures to improve heart function, alleviate symptoms, and improve quality of life. The end-use scope primarily spans hospitals, specialized heart care centers, and clinics. Market growth is influenced by technological advancements, which enhance device efficacy and patient outcomes, alongside rising healthcare expenditure and supportive government policies. Opportunities in the market include expanding healthcare infrastructure in emerging economies and innovations like the development of minimally invasive prosthetic devices. To capitalize on these opportunities, companies should focus on strategic partnerships, R&D investment in new technologies, and expansion into untapped markets. Nonetheless, limitations and challenges such as high costs, stringent regulatory requirements, risk of device-associated complications, and limited access to healthcare facilities in low-income regions hinder market growth. Innovation areas include developing more durable and biocompatible materials, enhancing battery life of electronic devices, and improving integration with digital health solutions. The market is dynamic, propelled by rapid innovation and competitive pressures, as companies strive to meet the evolving needs of healthcare providers and patients. Businesses are encouraged to focus on personalized medicine, leveraging data analytics for patient-specific devices, and increasing efforts toward patient awareness and education to foster greater acceptance and adherence. Continued research and product development, regulatory compliance, and strategic market positioning are pivotal for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Prosthetic Devices Market

The Cardiac Prosthetic Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of cardiovascular disease
  • Rising demand for minimally invasive surgery procedures
  • Growing awareness associated with CVD treatments
• Market Restraints
  • Fluctuation in anticoagulant medication level
• Market Opportunities
  • High potential for small pacemakers
  • Introduction of a new suture less aortic valve replacement
• Market Challenges
  • High need of repetitive surgeries

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Prosthetic Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Prosthetic Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Prosthetic Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Prosthetic Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Prosthetic Devices Market

A detailed market share analysis in the Cardiac Prosthetic Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Prosthetic Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Prosthetic Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Prosthetic Devices Market

A strategic analysis of the Cardiac Prosthetic Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Prosthetic Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Artivion, Inc., AtriCure, Inc., Biotronik SE & Co KG, Boston Scientific Corporation, Braile Biomedica, Colibri Heart Valve LLC, Edwards Lifesciences Corporation, Fortive Corporation, Lepu Medical Technology(Beijing)Co.,Ltd., LivaNova, PLC, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Microport Scientific Corporation, SGS Societe Generale de Surveillance SA., Shree Pacetronix Ltd., Siemens Healthineers AG, TZ Medical, Venus MedTech HangZhou Inc., and Vitatron Holding B.V..

Market Segmentation & Coverage

This research report categorizes the Cardiac Prosthetic Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Heart Valves and Pacemakers. The Heart Valves is further studied across Mechanical Valves, Tissue Valves, and Transcatheter Valves. The Tissue Valves is further studied across Stented Tissue Valve and Stentless Tissue Valve. The Pacemakers is further studied across External Pacemakers and Implantable Pacemakers.
• Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals, Clinics & Cardiac Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of cardiovascular disease
    • 5.1.1.2. Rising demand for minimally invasive surgery procedures
    • 5.1.1.3. Growing awareness associated with CVD treatments
  • 5.1.2. Restraints
    • 5.1.2.1. Fluctuation in anticoagulant medication level
  • 5.1.3. Opportunities
    • 5.1.3.1. High potential for small pacemakers
    • 5.1.3.2. Introduction of a new suture less aortic valve replacement
  • 5.1.4. Challenges
    • 5.1.4.1. High need of repetitive surgeries
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiac Prosthetic Devices Market, by Product

• 6.1. Introduction
• 6.2. Heart Valves
  • 6.2.1. Mechanical Valves
  • 6.2.2. Tissue Valves
    • 6.2.2.1. Stented Tissue Valve
    • 6.2.2.2. Stentless Tissue Valve
  • 6.2.3. Transcatheter Valves
• 6.3. Pacemakers
  • 6.3.1. External Pacemakers
  • 6.3.2. Implantable Pacemakers

7. Cardiac Prosthetic Devices Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals, Clinics & Cardiac Centers

8. Americas Cardiac Prosthetic Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Cardiac Prosthetic Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Prosthetic Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Artivion, Inc.
• 3. AtriCure, Inc.
• 4. Biotronik SE & Co KG
• 5. Boston Scientific Corporation
• 6. Braile Biomedica
• 7. Colibri Heart Valve LLC
• 8. Edwards Lifesciences Corporation
• 9. Fortive Corporation
• 10. Lepu Medical Technology(Beijing)Co.,Ltd.
• 11. LivaNova, PLC
• 12. Medtronic PLC
• 13. Meril Life Sciences Pvt. Ltd.
• 14. Microport Scientific Corporation
• 15. SGS Societe Generale de Surveillance SA.
• 16. Shree Pacetronix Ltd.
• 17. Siemens Healthineers AG
• 18. TZ Medical
• 19. Venus MedTech HangZhou Inc.
• 20. Vitatron Holding B.V.